DE69123795D1 - Pharmazeutische Zusammensetzung zur rektalen Verabreichung von Wirkstoffen mit topischer medizinischer Wirkung im Dickdarmniveau - Google Patents

Pharmazeutische Zusammensetzung zur rektalen Verabreichung von Wirkstoffen mit topischer medizinischer Wirkung im Dickdarmniveau

Info

Publication number
DE69123795D1
DE69123795D1 DE69123795T DE69123795T DE69123795D1 DE 69123795 D1 DE69123795 D1 DE 69123795D1 DE 69123795 T DE69123795 T DE 69123795T DE 69123795 T DE69123795 T DE 69123795T DE 69123795 D1 DE69123795 D1 DE 69123795D1
Authority
DE
Germany
Prior art keywords
rectal administration
pharmaceutical composition
active ingredients
medicinal effects
topical medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69123795T
Other languages
English (en)
Other versions
DE69123795T2 (de
DE69123795T3 (de
Inventor
Giuliano Frigerio
Gabriele Brunetti
Enzo Giorgetti
Emilia Chiodini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Giuliani SpA
Original Assignee
Giuliani SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11176813&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69123795(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Giuliani SpA filed Critical Giuliani SpA
Application granted granted Critical
Publication of DE69123795D1 publication Critical patent/DE69123795D1/de
Publication of DE69123795T2 publication Critical patent/DE69123795T2/de
Publication of DE69123795T3 publication Critical patent/DE69123795T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69123795T 1990-07-27 1991-06-14 Pharmazeutische Zusammensetzung zur rektalen Verabreichung von Wirkstoffen mit topischer medizinischer Wirkung im Dickdarmniveau Expired - Lifetime DE69123795T3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02110490A IT1243379B (it) 1990-07-27 1990-07-27 Composizione farmaceutica adatta alla somministrazione rettale di principi attivi che esplicano un'azione di medicazione a livello del colon prevalentemente di tipo topico

Publications (3)

Publication Number Publication Date
DE69123795D1 true DE69123795D1 (de) 1997-02-06
DE69123795T2 DE69123795T2 (de) 1997-07-10
DE69123795T3 DE69123795T3 (de) 2001-07-12

Family

ID=11176813

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69123795T Expired - Lifetime DE69123795T3 (de) 1990-07-27 1991-06-14 Pharmazeutische Zusammensetzung zur rektalen Verabreichung von Wirkstoffen mit topischer medizinischer Wirkung im Dickdarmniveau

Country Status (10)

Country Link
US (1) US5449520A (de)
EP (1) EP0468555B2 (de)
JP (1) JP3291301B2 (de)
AT (1) ATE146674T1 (de)
CA (1) CA2044676C (de)
DE (1) DE69123795T3 (de)
DK (1) DK0468555T4 (de)
ES (1) ES2097787T5 (de)
GR (2) GR3022790T3 (de)
IT (1) IT1243379B (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9414699D0 (en) * 1994-07-21 1994-09-07 Slagel David Aqueous foamable composition
DE4446891A1 (de) * 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
CN1172433A (zh) * 1995-02-02 1998-02-04 中外制药株式会社 胃溃宁制剂
AU721566B2 (en) 1995-06-27 2000-07-06 Boehringer Ingelheim Kg New stable pharmaceutical preparation for producing propellant-free aerosols
IT1277663B1 (it) * 1995-09-28 1997-11-11 Crinos Industria Farmaco Sospensioni acquose stabili di mesalazina per uso topico
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
US6239120B1 (en) 1998-03-17 2001-05-29 Pharmalink Ab Method and means for treating glomerulonephritis
US6326364B1 (en) * 1999-02-08 2001-12-04 Cedars-Sinai Medical Center Use of 5-aminosalicylates as antimicrobial agents
DE19941933A1 (de) * 1999-09-03 2001-03-15 Cognis Deutschland Gmbh Tensidsysteme
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
EP1312368A1 (de) * 2001-11-19 2003-05-21 Dr. Falk Pharma Gmbh Zusammensetzungen enthaltend Mesalazin zur Behandlung von entzündlichen Darmerkrankungen
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
MXPA05004278A (es) 2002-10-25 2005-10-05 Foamix Ltd Espuma cosmetica y farmaceutica.
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US9668972B2 (en) * 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
JP2005015365A (ja) * 2003-06-25 2005-01-20 Koike Kagaku Kk エアゾール型洗浄消毒剤
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
EP1981480A1 (de) * 2006-01-19 2008-10-22 Disphar International B.V. Schaumbildende zusammensetzung
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US7645801B2 (en) 2007-01-29 2010-01-12 Alaven Pharmaceutical Llc Reduced irritant enema for treatment of inflammatory bowel disease (IBD)
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
EP2242476A2 (de) 2008-01-14 2010-10-27 Foamix Ltd. Aufschäumbare pharmazeutische poloxamer-zusammensetzungen mit wirkstoffen und/oder therapeutischen zellen und verwendungen
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
MX359879B (es) 2009-10-02 2018-10-12 Foamix Pharmaceuticals Ltd Composiciones tópicas de tetraciclina.
AU2010320656B2 (en) 2009-11-23 2015-07-30 Cipla Limited Topical foam composition
NZ600358A (en) 2009-11-23 2014-05-30 Cipla Ltd Topical foam composition
US8174881B2 (en) 2009-11-24 2012-05-08 Micron Technology, Inc. Techniques for reducing disturbance in a semiconductor device
EP3115037B1 (de) 2015-07-08 2018-08-15 Dr. Falk Pharma Gmbh Pharmazeutische formulierung zur behandlung von entzündlichen veränderungen des enddarms
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
EP3554473A1 (de) * 2016-12-16 2019-10-23 Ferring B.V. Rektalschaumformulierungen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0015334B1 (de) * 1977-08-04 1982-05-19 J.B. Tillott Limited Pfefferminzöl oder dessen aktive Bestandteile enthaltende Carminativa
JPS5921613A (ja) * 1982-07-28 1984-02-03 Takeda Chem Ind Ltd 直腸投与製剤
US4664256A (en) * 1983-09-06 1987-05-12 Farmaceutisk Laboratorium Ferring A/S Packaged stable enema solution or suspension containing 5-aminosalicyclic acid
US4609403A (en) * 1984-03-12 1986-09-02 Warner-Lambert Company Foam soft gelatin capsules and their method of manufacture
US4814183A (en) * 1987-08-31 1989-03-21 Merck & Co., Inc. Device for the controlled release of drugs with Donnan-like modulation by charged insoluble resins
US5206268A (en) * 1988-08-16 1993-04-27 Burroughs Wellcome Co. Medicaments
GB8909559D0 (en) * 1989-04-26 1989-06-14 Smith Kline French Lab Pharmaceutical compositions
FR2647344B1 (fr) * 1989-05-25 1995-06-02 Physiopharm Sarl Mousse aerosol a usage rectal

Also Published As

Publication number Publication date
IT9021104A1 (it) 1992-01-27
GR3035634T3 (en) 2001-06-29
DK0468555T4 (da) 2001-04-02
DE69123795T2 (de) 1997-07-10
IT9021104A0 (it) 1990-07-27
DE69123795T3 (de) 2001-07-12
JP3291301B2 (ja) 2002-06-10
EP0468555A1 (de) 1992-01-29
IT1243379B (it) 1994-06-10
EP0468555B1 (de) 1996-12-27
JPH04234315A (ja) 1992-08-24
CA2044676A1 (en) 1992-01-28
DK0468555T3 (da) 1997-06-09
ES2097787T5 (es) 2001-04-01
US5449520A (en) 1995-09-12
ES2097787T3 (es) 1997-04-16
ATE146674T1 (de) 1997-01-15
GR3022790T3 (en) 1997-06-30
CA2044676C (en) 2003-04-01
EP0468555B2 (de) 2001-02-07

Similar Documents

Publication Publication Date Title
DE69123795D1 (de) Pharmazeutische Zusammensetzung zur rektalen Verabreichung von Wirkstoffen mit topischer medizinischer Wirkung im Dickdarmniveau
DE19375061I2 (de) Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.
DE69109284T2 (de) Verwendung von fluorierten löslichen tensiden zur herstellung von aerosolarzneimitteln mit dosierter abgabe.
DE68919146D1 (de) Ausgewählte Stämme von Lactobacillus enthaltende pharmazeutische Zusammensetzungen.
FI941771A (fi) Tehostettu ihonläpäisyjärjestelmä lääkeaineiden parannettua paikallista antoa varten
IT8621358A0 (it) Composizione farmaceutica adattivita' analgesica.
DE3768419D1 (de) Pharmazeutische zusammensetzungen mit antineoplastischer wirkung.
IT1212778B (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
ITMI922603A1 (it) Composizioni farmaceutiche comprendenti un farmaco, una sostanza polimerica reticolata, un olio ed un agente tensioattivo
IT1190824B (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
DE69928815D1 (de) Dosierungsform mit flüssiger formulierung
ITRM910002A1 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
ATE97001T1 (de) Topisch anzuwendende defibrotid enthaltende arzneizubereitungen.
DE3576505D1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.
DK0453603T3 (da) Piroxicamholdige farmaceutiske præparater til topisk anvendelse
DE3578597D1 (de) 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
ATE132877T1 (de) Emulgatorfreie emulsionspolymere in pharmazeutischen zubereitungen mit verzögerter wirkstofffreigabe und ihre herstellung
ATE145333T1 (de) Hirudin enthaltende orale arzneimittel
FR2677250B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique.
DE68907609D1 (de) Arzneimittelzusammensetzung.
DE3484155D1 (de) Fr-900216-verbindung, durch kultivierung von atcc 20577 gewonnen, als aktive therapeutische verbindung genutzt, und sie enthaltende antitumorale pharmazeutische zusammensetzung von fr-900216.
IT9048244A0 (it) Composizione farmaceutica ad effetto cicatrizzante.
IT8421627A0 (it) Composizione farmaceutica contenente come ingrediente attivo 24,25-diidrossicolecalciferolo.
MX9102627A (es) Composicion farmaceutica de dobutamina para administracion transdermica.
IT8621925A0 (it) Composizioni farmaceutiche adattivita' antineoplastica.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings